Clinical Trials

Clinical Trials News

Market immunity? How public safety warnings have little impact on drug sales volumes or pharma company share prices
World

Market immunity? How public safety warnings have little impact on drug sales volumes or pharma company share prices

Under the system used by drug regulators in the US, Europe and elsewhere, drug companies need only show from clinical trials that new drugs have short-term safety and efficacy in order to gain approval

When is the ideal time for children to get the COVID-19 vaccine? Experts give their opinion
India

When is the ideal time for children to get the COVID-19 vaccine? Experts give their opinion

Arora said, "Very soon, mRNA vaccine is also coming. Based on international data, it is very encouraging that we can use that for children."

SEC recommends DCGI to approve Bharat Biotech's Covaxin for children between 2-18 years of age
India

SEC recommends DCGI to approve Bharat Biotech's Covaxin for children between 2-18 years of age

If approved, the two-dose vaccine will be given to children within 20 days apart.

Hopeful of beginning vaccination for children aged 5-11 by end-2021, says FDA vaccine chief
World

Hopeful of beginning vaccination for children aged 5-11 by end-2021, says FDA vaccine chief

In the US, anyone 12 and older is eligible for the vaccine but with the new variants and schools reopening, parents are wondering when younger children can get the shots.

Trial participants will be issued digital vaccine certificates: Health Ministry
India

Trial participants will be issued digital vaccine certificates: Health Ministry

The ICMR was designated as the nodal agency for the collection of vaccination data for such participants by the ministry.

Azerbaijan trial studying effects of combined Sputnik and AstraZeneca vaccines reports positive results
science

Azerbaijan trial studying effects of combined Sputnik and AstraZeneca vaccines reports positive results

When contacted for their response to the latest development, both Serum Institute of India and Dr Reddy's Laboratories refused to comment at this time.

WHO's Solidarity trial will test three new potential COVID-19 drugs in new phase
science

WHO's Solidarity trial will test three new potential COVID-19 drugs in new phase

The study began in June 2021 and will continue till May 2022 and is being conducted in over 600 hospitals in 52 countries.

COVID-19 survivors are twice as likely to get re-infected, are urged to get vaccinated
science

COVID-19 survivors are twice as likely to get re-infected, are urged to get vaccinated

Vaccinated survivors can make antibodies that can recognize all kinds of variants even if you were never exposed to the variant.

Bharat Biotech’s intranasal vaccine for COVID-19: Everything we know so far about BBV154
India

Bharat Biotech’s intranasal vaccine for COVID-19: Everything we know so far about BBV154

The intranasal vaccine BBV154 is being tested to check if it prevents infection, halts person-to-person transmission, and progression of COVID-19.

CureVac’s COVID-19 mRNA vaccine disappoints in preliminary results as it shows 47 percent efficacy
World

CureVac’s COVID-19 mRNA vaccine disappoints in preliminary results as it shows 47 percent efficacy

Franz-Werner Haas, chief executive blamed the results on the high number of variants in the countries where the vaccine was tested.

Bharat Biotech's Covaxin trials on children between 2-18 years of age amounts to homicide: Plea in Delhi HC
India

Bharat Biotech's Covaxin trials on children between 2-18 years of age amounts to homicide: Plea in Delhi HC

Petitioner Sanjeev Kumar said the children could suffer adverse health or mental effects due to the vaccine testing.

Health ministry to buy 30 cr COVID-19 vaccine doses from Biological-E for Rs 1,500 cr
India

Health ministry to buy 30 cr COVID-19 vaccine doses from Biological-E for Rs 1,500 cr

The vaccine recently got the nod of approval for phase-3 clinical trials after showing promising results in phase 1 and 2.

Hyderabad-based Biological E to manufacture Canadian firm Providence's COVID 19 vaccine
India

Hyderabad-based Biological E to manufacture Canadian firm Providence's COVID 19 vaccine

Biological E will conduct a bridging trial for the vaccine in India and also manufacture the vaccine.

Centre says mixing COVID-19 vaccines a possibility, foreign studies make a strong case
World

Centre says mixing COVID-19 vaccines a possibility, foreign studies make a strong case

Niti Aayog member VK Paul has said that mixing COVID-19 vaccines is plausible, but "there need to be more studies."

SEC recommends Bharat Biotech’s Covaxin phase 2, 3 clinical trials on 2- to 18-year-olds
India

SEC recommends Bharat Biotech’s Covaxin phase 2, 3 clinical trials on 2- to 18-year-olds

The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS Patna and Meditrina Institute of Medical Sciences, Nagpur.

Pfizer-BioNTech COVID-19 vaccine may come to India, emergency approval on the cards
India

Pfizer-BioNTech COVID-19 vaccine may come to India, emergency approval on the cards

In April, the US pharma company had offered a not-for-profit price for its vaccine for the Indian government's immunisation programme.

India will review claims of AstraZeneca vaccine causing blood clots in 'unusual' sites
India

India will review claims of AstraZeneca vaccine causing blood clots in 'unusual' sites

There have been no reports of cases in India, authorities are still looking into claims as many countries have either stopped or limited the use of the vaccine.

AstraZeneca's Britain COVID-19 vaccine clinical trials for children paused due to blood clot concerns
World

AstraZeneca's Britain COVID-19 vaccine clinical trials for children paused due to blood clot concerns

Britain and the vaccine's developers had until now resisted any restrictions in its use, saying that there was no proof of any link.

Researchers are hatching a new low-cost COVID-19 vaccine in chicken eggs
science

Researchers are hatching a new low-cost COVID-19 vaccine in chicken eggs

If NDV-HXP-S proves safe and effective, flu vaccine manufacturers could potentially produce well over a billion doses of it a year.

Do not use 'miracle cure' ivermectin on COVID-19 patients says WHO
science

Do not use 'miracle cure' ivermectin on COVID-19 patients says WHO

Like anti-malaria drug hydroxychloroquine — so far unproven by clinical trials — ivermectin is widely available and cheap.